Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "A06AX" (22)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Glycerol (A06AX01) 8 products
WHO-DDD
DrugBank.ca
IP
CI
CM
Amavita Glycolax
18
k.A.
Suppositories: Glycerolum 2250 mg
Amavita Health Care AG
D / LPPV
FB
G
IP
CI
Bulboid für Säuglinge und
Kinder
10 suppositories
k.A.
Suppositories: Glycerolum 878 mg
Melisana AG
D / LPPV
FB
G
IP
CI
Bulboid für Erwachsene
10 suppositories
k.A.
Suppositories: Glycerolum 1.756 g
Melisana AG
D / LPPV
FB
G
IP
CI
Bulboid für Erwachsene
100 suppositories
k.A.
Suppositories: Glycerolum 1.756 g
Melisana AG
D / LPPV
FB
G
IP
CI
CM
Coop Vitality Glycolax
18
k.A.
Suppositories: Glycerolum 2250 mg
Coop Vitality Health
Care GmbH
D
FB
G
IP
CI
Glycerin ELK Pharma
18
k.A.
Suppositories: Glycerolum 2250 mg
mmpharm GmbH
D / LPPV
FB
G
IP
CI
CM
SUN STORE Glycolax
18
k.A.
Suppositories: Glycerolum 2250 mg
Sun Store Health Care AG
D
FB
G
IP
CI
Supposte di glicerina
Fonte SA
18 suppositories
8.30
k.A.
supposte per adulti: Glycerolum 2250 mg
Fonte SA
D / LPPV
FB
G
Carbon Dioxide Producing Drugs (A06AX02) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Lecicarbon
10 suppositories
7.55
k.A.
Suppositories: 2 Active Agents
athenstaedt AG
D / LPPV
FB
G
IP
CI
Lecicarbon
10 suppositories
10.25
k.A.
Suppositories: 2 Active Agents
athenstaedt AG
D / LPPV
FB
G
IP
CI
Lecicarbon
100 suppositories
71.15
k.A.
Suppositories: 2 Active Agents
athenstaedt AG
D / LPPV
FB
G
Linaclotide (A06AX04) 7 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Constella
28 Capsule(s)
52.28
73.25
10 %
Capsules: Linaclotidum
AbbVie AG
B / SL
FB
G
IP
CI
PP
Constella
90 Capsule(s)
142.84
171.75
10 %
Capsules: Linaclotidum
AbbVie AG
B / SL
FB
G
IP
CI
Axulta
7
k.A.
Capsules: Linaclotidum
AstraZeneca AG
FB
G
IP
CI
Axulta
10
k.A.
Capsules: Linaclotidum
AstraZeneca AG
FB
G
IP
CI
Axulta
28
k.A.
Capsules: Linaclotidum
AstraZeneca AG
FB
G
IP
CI
Axulta
60
k.A.
Capsules: Linaclotidum
AstraZeneca AG
FB
G
IP
CI
Axulta
90
k.A.
Capsules: Linaclotidum
AstraZeneca AG
FB
G
Prucalopride (A06AX05) 4 products
WHO-DDD
DrugBank.ca
L
IP
CI
Resolor 1 mg
28 Tablet(s)
36.85
56.50
10 %
Coated tablets: Prucalopridum 1 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Resolor 2 mg
28 Tablet(s)
60.44
82.15
10 %
Coated tablets: Prucalopridum 2 mg
Takeda Pharma AG
B / SL
FB
G
Prucaloprid Spirig HC 1 mg
28
k.A.
Coated tablets: Prucalopridum 1 mg
Spirig HealthCare AG
B
FB
G
Prucaloprid Spirig HC 2 mg
28
k.A.
Coated tablets: Prucalopridum 2 mg
Spirig HealthCare AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
